Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
www.ahrq.gov

NHQR Resources
State Resources for Taking Action
User Guide for NHQR Web Sites

2011 State Snapshots Home
Getting Started
State Selection Map
What's New
State-Specific Information
State Dashboard
Overall Health Care Quality
Strongest and Weakest Measures
Types of Care
Settings of Care
Care by Clinical Area
Focus on Diabetes
 Prevalence
 Quality of Care
 Quality Improvement
 
Disparities in Treatment
  By Income
  
By Race/Ethnicity
Focus on Asthma
Focus on Healthy People 2020
Focus on Clinical Preventive Services
Focus on Disparities
Focus on Payer
Focus on Variation Over Time
State Rankings for Selected Measures
Contextual Factors
Other Information
All-State Data Tables for All Measures
Snapshot Print Version
Other State Snapshot Years
Interpretation of Results
Methods
Technical Assistance

Related Links
Measuring Healthcare Quality
Health Care Report Card Compendium
Health Care Innovations Exchange
 

Washington

Focus on Diabetes:

Disparities in Treatment: HbA1c Testing for Blacks, Hispanics, and Whites

For a few States, racial/ethnic groups also can be evaluated for HbA1c monitoring. When sufficient data are available, the maps below show whether the gap in the rate of HbA1c testing among different racial groups and Whites within a State is worse than, similar to, or better than the gap that exists across all States with data. The bar chart shows the actual percentage of people with diabetes in racial and ethnic groups who receive HbA1c monitoring in the State (if available), in the region, and in all States.


For 2007-2009, The Gap in HbA1c Testing for People with Diabetes for Non-Hispanic Blacks Compared to Non-Hispanic Whites.

For 2007-2009, The Gap in HbA1c Testing for People with Diabetes for Non-Hispanic Blacks Compared to Non-Hispanic Whites.The gap between Blacks and Whites is worse (red), similar (yellow), or better (green) than the all-State gap. Unknown or insufficient data is represented by no color.


HbA1c monitoring uses a blood test that indicates to a health care provider how well a patient's diabetes has been controlled. It is an important test that helps providers monitor and guide patients to minimize and avoid serious complications. In the map above:

  • Worse than the all-State gap means the gap in HbA1c testing between non-Hispanic Black people with diabetes and non-Hispanic White people with diabetes is worse than the gap between these groups across all States with data.
  • Similar to the all-State gap means the gap in HbA1c testing between non-Hispanic Black people with diabetes and non-Hispanic White people with diabetes is similar to the gap between these groups across all States with data.
  • Better than the all-State gap means the gap in HbA1c testing between non-Hispanic Black people with diabetes and non-Hispanic White people with diabetes is better than the gap between these groups across all States with data.
  • Unknown/data insufficient means a measure for the State could not be made.
For 2007-2009, The Gap in HbA1c Testing for People with Diabetes for Non-Hispanic Blacks Compared to Non-Hispanic Whites. The gap is worse than the all-State gap in the following States: Illinois The gap is similar to the all-State gap in the following States: Alabama, Arkansas, California, Connecticut, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Massachusetts, Michigan, Mississippi, Missouri, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Washington, and Wisconsin. The gap is better than the all-State gap in the following States: Indiana, Nevada, New Jersey, and West Virginia. There is insufficient data for these States: Alaska, Arizona, Colorado, Hawaii, Idaho, Iowa, Kansas, Maine, Maryland, Minnesota, Montana, Nebraska, New Hampshire, New Mexico, New York, North Dakota, Oregon, Rhode Island, South Dakota, Utah, Vermont, and Wyoming.

These categories are based on comparisons of the relative rates of HbA1c testing for people with diabetes within the two race/ethnicity groups in each State relative to the all-State rates for those race/ethnicity groups, for the period 2007–2009. Data are from the Behavioral Risk Factor Surveillance System. For more information, select Methods.


For 2007-2009, The Gap in HbA1c Testing for People with Diabetes for Hispanics Compared to Non-Hispanic Whites.

For 2007-2009, The Gap in HbA1c Testing for People with Diabetes for Hispanics Compared to Non-Hispanic Whites.The gap between Hispanics and Whites is worse (red), similar (yellow), or better (green) than the all-State gap. Unknown or insufficient data is represented by no color.

HbA1c monitoring uses a blood test that indicates to a health care provider how well a patient's diabetes has been controlled. It is an important test that helps providers monitor and guide patients to minimize and avoid serious complications. In the map above:

  • Worse than the all-State gap means the gap in HbA1c testing between Hispanic people with diabetes and non-Hispanic White people with diabetes is worse than the gap between these groups across all States with data.
  • Similar to the all-State gap means the gap in HbA1c testing between Hispanic people with diabetes and non-Hispanic White people with diabetes is similar to the gap between these groups across all States with data.
  • Better than the all-State gap means the gap in HbA1c testing between Hispanic people with diabetes and non-Hispanic White people with diabetes is better than the gap between these groups across all States with data.
  • Unknown/data insufficient means a measure for the State could not be made.
For 2007-2009, The Gap in HbA1c Testing for People with Diabetes for Hispanics Compared to Non-Hispanic Whites. The gap is worse than the all-State gap in the following States: Alabama, Arizona, Florida, Massachusetts, New Jersey, Texas, Utah, and Virginia. The gap is similar to the all-State gap in the following States: Colorado, Connecticut, Idaho, and Washington. The gap is better than the all-State gap in the following States: California, Georgia, Hawaii, Indiana, Kentucky, Louisiana, Nevada, New Mexico, North Carolina, Pennsylvania, South Carolina, and Wyoming. There is insufficient data for these States: Alaska, Arkansas, Delaware, District of Columbia, Illinois, Iowa, Kansas, Maine, Maryland, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, New Hampshire, New York, North Dakota, Ohio, Oklahoma, Oregon, Rhode Island, South Dakota, Tennessee, Vermont, West Virginia, and Wisconsin.

These categories are based on comparisons of the relative rates of HbA1c testing for people with diabetes within the two race/ethnicity groups in each State relative to the all-State rates for those race/ethnicity groups, for the period 2007–2009. Data are from the Behavioral Risk Factor Surveillance System. For more information, select Methods.

The chart below shows the actual rates of HbA1c monitoring for people who are non-Hispanic Black, Hispanic, or non-Hispanic White within the State, the region, and all States. Any missing bars reflect insufficient data for a group within the State.

Percent of People in Washington With Diabetes Who Had an HbA1c Test, by Race/Ethnicity, 2007 to 2009.

Percent of People in Washington With Diabetes Who Had an HbA1c Test, by Race/Ethnicity, 2007 to 2009.
Percent of People in Washington With Diabetes Who Had an HbA1c Test, by Race/Ethnicity, 2007 to 2009. Bar chart. For Non-Hispanic Blacks, the percentage in Washington is 90.4; the percentage in the Pacific States is 98.2; and the percentage in all States is 89.4. For Hispanics, the percentage in Washington is 83.5; the percentage in the Pacific States is 98.0; and the percentage in all States is 82.3. For Non-Hispanic Whites, the percentage in Washington is 92.0; the percentage in the Pacific States is 94.8; and the percentage in all States is 91.8.

The bar chart represents the percent of people with diabetes who had an HbA1c test in the previous 12 months for the period 2007–2009. Data are from the Behavioral Risk Factor Surveillance System. For more information, select Methods.